We could deliver industry-leading AAV packaging services to support your gene therapy projects. Our proprietary production platform, featuring optimized cell lines and enhanced RC and helper plasmids, maximizes virus yield. With years of expertise, we have perfected protocols to produce over 70 AAV serotypes with high titer, purity, potency, and consistency.

We offer end-to-end lentiviral vector design and packaging services, leveraging proprietary technologies and reagents for superior quality. Our optimized packaging enhances titer, purity, viability, and consistency, particularly for third-generation lentiviral vectors. Unlike plasmid DNA, which enables only transient expression, lentiviral vectors integrate transgenes into the host genome for stable expression across diverse cell types, including neurons, liver, heart, tumor, endothelial, and stem cells. Well-tolerated in mammalian systems, lentiviral vectors are suitable for both in vitro and in vivo applications.

We provide one-stop service from gene synthesis to lentivirus packaging. From gene synthesis to lentivirus manufacturing, we handle every step, including GOI, shRNA, or gRNA synthesis.